Evidence map›Paper›PMID 33961141›Full record

ReviewCurrent hypertension reports2021

Impact of Nutritional Epigenetics in Essential Hypertension: Targeting microRNAs in the Gut-Liver Axis.

Rachel M Golonka, Johnathan Kawika Cooper, Rochell Issa, Pratyush Pavan Devarasetty, Veda Gokula, Joshua Busken, Jasenka Zubcevic, Jennifer Hill, Matam Vijay-Kumar, Bindu Menon and 1 more

Open access · hybridAbstract readReview
In one paragraph

Review in Current hypertension reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Rachel M GolonkaMicrobiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Block Health Science Bldg, 3000 Arlington Ave, Toledo, OH, 43614, USA.
Johnathan Kawika Cooper *The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Rochell Issa *The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Pratyush Pavan Devarasetty *The University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Veda GokulaThe University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Joshua BuskenThe University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA.
Jasenka ZubcevicMicrobiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Block Health Science Bldg, 3000 Arlington Ave, Toledo, OH, 43614, USA.
Jennifer HillMicrobiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Block Health Science Bldg, 3000 Arlington Ave, Toledo, OH, 43614, USA.
Matam Vijay-KumarMicrobiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Block Health Science Bldg, 3000 Arlington Ave, Toledo, OH, 43614, USA.
Bindu MenonDepartment of Medical Education, University of Toledo College of Medicine and Life Sciences, Room 3105B, CCE Bldg, 2920 Arlington Ave, Toledo, OH, 43614, USA. bindu.menon@utoledo.edu.
Bina JoeMicrobiome Consortium, Center for Hypertension and Precision Medicine, Department of Physiology and Pharmacology, The University of Toledo College of Medicine and Life Sciences, Block Health Science Bldg, 3000 Arlington Ave, Toledo, OH, 43614, USA. bina.joe@utoledo.edu.ORCID http://orcid.org/0000-0002-2385-7061
University of Toledo · USUniversity of Florida · USUniversity of Toledo Medical Center · US

Funding

Neural mechanisms of host-microbiota interaction in hypertension: a potential for bio-electronic medicineR01HL152162 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI ZUBCEVIC, JASENKA · 2021 to 2025
$2.2M
Interplay between Dietary Fiber and Gut Microbiota in Hepatocellular CarcinomaR01CA219144 · NCI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI VIJAY-KUMAR, MATAM · 2017 to 2021
$1.6M
Gut-brain axis: functional link between microbial metabolites and neurogenic hypertensionR21AT010192 · NCCIH · UNIVERSITY OF FLORIDA · PI MARTYNIUK, CHRISTOPHER JOSEPH · 2019 to 2020
$419k
NCCIH NIH HHS R21 AT010192NCI NIH HHS R01 CA219144NHLBI NIH HHS R01 HL152162
6 · The paper itself

Abstract

purpose of reviewTo review the current knowledge on interactions between dietary factors and microRNAs (miRNAs) in essential hypertension (EH) pathogenesis. RECENT

findingsThere exists an integration of maintenance signals generated by genetic, epigenetic, immune, and environmental (e.g., dietary) factors that work to sustain balance in the gut-liver axis. It is well established that an imbalance in this complex, intertwined system substantially increases the risk for EH. As such, pertinent research has been taken to decipher how each signal operates in isolation and together in EH progression. Recent literature indicates that both macro- and micronutrients interrupt regulatory miRNA expressions and thus, alter multiple cellular processes that contribute to EH and its comorbidities. We highlight how carbohydrates, lipids, proteins, salt, and potassium modify miRNA signatures during EH. The disruption in miRNA expression can negatively impact communication systems such as over activating the renin-angiotensin-aldosterone system, modulating the vascular smooth muscle cell phenotype, and promoting angiogenesis to favor EH. We also delineate the prognostic value of miRNAs in EH and discuss the pros and cons of surgical vs dietary prophylactic approaches in EH prevention. We propose that dietary-dependent perturbation of the miRNA profile is one mechanism within the gut-liver axis that dictates EH development.

Indexed as

HypertensionMicroRNAsEpigenesis, GeneticEssential HypertensionHumansLiverRenin-Angiotensin SystemMicroRNAsBariatric surgeryGut microbiomeHyperlipidemiaRenin-angiotensin-aldosterone systemVasculature

Identifiers

PMID33961141
PMCPMC8105193
OpenAlexW3158647964

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.